Jordan Levitt, founding partner of revenue cycle solution provider PayorLogic, spoke with Becker’s Hospital Review to discuss the rule’s potential effects on healthcare revenue cycles.
Mr. Levitt believes the rule is a first step toward combatting an important issue in care reimbursement, but contends the “implications could be significant,” especially during initial implementation stages.
Under the final rule, CMS will require a certain subset of high dollar/high frequency durable medical equipment prosthetics, orthotics and supplies to be authorized prior to distribution rather than after the fact, according to Mr. Levitt. If the authorization process is successfully streamlined, Mr. Levitt believes the new timeline could certainly help reduce both fraud and payment related surprises for all parties involved.
“However, the 10-day turnaround timeframe committed to by CMS is a bit long, especially considering the high volume and urgency of these items,” says Mr. Levitt. Inefficiencies and care delays could adversely affect both providers and patients, for which patient care and patient satisfaction could suffer, Mr. Levitt adds.
“Applying a gate keeper before a process versus after a process clearly makes sense, but the process needs to be appropriately supported and understood by all stakeholders,” says Mr. Levitt.
More articles on revenue cycle management:
Clinicient secures $5M in debt funding to expand niche RCM services
HealthWell Foundation to help renal cell carcinoma patients with their co-pays
3 costly healthcare megatrends to watch in 2016
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
